Clinical Genomics is a leading provider of colorectal cancer testing including COLVERA™, a liquid biopsy blood test identifying ctDNA for early detection of residual and recurrent CRC in post-treatment patients and InSure® ONE™, a one sample fecal immunochemical test for screening programs to detect lower GI bleeding in healthy adults. Clinical Genomics is committed to delivering solutions that provide physicians with information to guide earlier treatment decisions in cancer care management.